13 November 2024 - Australia’s audit office will probe the Morrison Government’s $2 billion deal with US pharmaceutical giant Moderna to set up vaccine manufacturing in Australia as the firm races to meet its promised timeline while a spurned local rival begins shipping COVID jabs overseas.
Sources familiar with the project told this masthead that Australian vaccine manufacturer CSL had offered to make inoculations here for a much cheaper price but lost out on the contract to Moderna, which does not yet have regulatory approval to produce the vaccines in its Melbourne factory. The Coalition promised vaccine production would start in 2024.